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The ability to induce autologous tissue-specific stem
cells in culture could have a variety of applications in
regenerative medicine and disease modeling. Here
we show that transient expression of exogenous
YAP or its closely related paralogue TAZ in primary
differentiated mouse cells can induce conversion to
a tissue-specificstem/progenitor cell state.Differenti-
ated mammary gland, neuronal, and pancreatic
exocrine cells, identified using a combination of cell
sorting and lineage tracing approaches, efficiently
convert to proliferating cells with properties of stem/
progenitor cells of their respective tissues after YAP
induction. YAP-induced mammary stem/progenitor
cells showmolecular and functional properties similar
to endogenous MaSCs, including organoid formation
and mammary gland reconstitution after transplanta-
tion. Because YAP/TAZ function is also important for
self-renewal of endogenous stem cells in culture,
our findings have implications for understanding the
moleculardeterminantsof thesomaticstemcell state.
INTRODUCTION
Stem cells (SCs) display the capacity to self-renew when they
divide and to generate a differentiated progeny. Somatic SCs
operate in multiple adult organs for continuous tissue renewal
or repair after injury. However, these cells are still mainly defined
by operational definitions and cell surface markers, rather than
the molecular traits that govern their special status (Blanpain
and Fuchs, 2014). Unlimited availability of normal, somatic SCs
will be critical for effective organ repopulation in regenerative
medicine applications to understand SC biology and for disease
modeling in the Petri dish. However, these efforts remain limited
by the fact that SCs are rare and difficult to purify or expand from
native tissues.Cell Stem Cell 19, 725–737, Dec
This is an open access article undDirect conversion of terminally differentiated cells back into
their corresponding tissue-specific SCs may represent an
attractive approach to obtain somatic SCs. Indeed, several re-
ports have recently highlighted a surprising plasticity in somatic
cell fates because differentiated cells can return to a SC status
under special conditions, such as tissue damage (Blanpain and
Fuchs, 2014). However, the identity of the factors able to control
the somatic SC status remains poorly understood, limiting the
exploitation of such plasticity.
Dysregulation of the Hippo signaling pathway has been
recently associated with cell fate plasticity. In tumors, activation
of the Hippo pathway transcriptional effectors YAP/TAZ can
reprogram non-stem cancer cells into cancer SCs (Cordenonsi
et al., 2011). Genetic inactivation of the Hippo cascade induces
liver overgrowth, in part by influencing liver cell fate and zonation
(Lee et al., 2016; Yimlamai et al., 2014; Fitamant et al., 2015).
Nuclear YAP/TAZ proteins are found in anatomical locations en-
riched in tissue SCs, possibly as a consequence of their regula-
tion by structural and chemical signals associated with the SC
niche (Piccolo et al., 2014). That said, genetic ablation of YAP
and/or TAZ from several adult organs in mice, such as liver,
pancreas, intestine, and mammary gland, revealed that these
factors are surprisingly dispensable during normal tissue ho-
meostasis. Strikingly, however, in those same tissues, YAP/
TAZ become essential for organ regrowth after tissue damage
or oncogenic transformation (Azzolin et al., 2014; Zanconato
et al., 2016). This suggests that YAP/TAZ remain latent—and,
thus, apparently dispensable—in normal adult tissues but are
called into action to generate new stem cells.
With this background in mind, we considered the possibility
that ectopic expression of YAP or TAZ may be instrumental to
turn differentiated cells into somatic stem-like cells. Here we
tested this hypothesis in vitro by using distinct paradigms of ter-
minal differentiation; that is, luminal mammary gland cells, neu-
rons, and pancreatic exocrine cells. We found that transient
expression of YAP/TAZ indeed converts differentiated cells
into cells displaying multiple features of their corresponding tis-
sue-specific SCs. Notably, the ability of YAP/TAZ to impart an
SC state pairs with their endogenous function in isolated native
SCs, where they are essential for preserving organoid-formingember 1, 2016 ª 2016 The Authors. Published by Elsevier Inc. 725
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Figure 1. YAP and TAZ Convert Luminal
Differentiated Cells in yMaSCs
(A) FACS profile showing the distribution of Lin–/
EpCAM+ mammary cells according to their CD49f/
CD61 antigenic profile. Three subpopulations
were separated: a MaSC-enriched fraction
(EpCAMlowCD49fhighCD61+), luminal progenitors
(EpCAMhighCD49flowCD61+), and luminal differenti-
ated cells (EpCAMhighCD49flowCD61). See also
Figure S1A for the FACS pattern of EpCAM and
Figures S1B–S1E for characterization of the three
subpopulations.
(B) Western blots for YAP, TAZ, and the MaSC
marker p63 in the indicated purified populations.
GAPDH served as a loading control.
(C) qRT-PCRs for Ctgf and Axl in the indicated cell
populations (mean + SD). The results are repre-
sentative of three independent experiments (each
using mammary glands from 20 mice) performed in
triplicate.
(D) Schematic of the experiments performed with
LD cells.
(E and F) Representative images (E) and quantifi-
cations (F) of mammary colonies formed by the
indicated cells 15 days after seeding in mammary
colony medium. The data in (F) are presented
as mean + SD and are representative of five
independent experiments, each with six technical
replicates.
(G and H) Quantifications of secondary (G) and ter-
tiary (H) colonies formed by primary mammary col-
onies after dissociation and re-seeding in mammary
colony medium without doxycycline. The data are
representative of three independent experiments
performed with six technical replicates and pre-
sented as mean + SD.
See also Figure S1.potential. Our work therefore reveals that a single factor can
induce somatic stem cell features in cells of different lineages.
RESULTS
YAP/TAZ Revert Differentiated Cells of the Mammary
Gland into MaSC-like Cells
The mammary gland represents a classic model system for the
study of epithelial SCs and tissue regeneration. Remarkably, im-
plantation ofmammary gland SCs (MaSCs) into themammary fat
pad is sufficient to regenerate an entire ductal tree, with MaSCs726 Cell Stem Cell 19, 725–737, December 1, 2016contributing to both the luminal and myoe-
pithelial lineages (Blanpain and Fuchs,
2014). Given that YAP/TAZ can reprogram
non-stem mammary tumor cells into their
corresponding cancer stem cells (CSCs)
(Cordenonsi et al., 2011), we hypothesized
that expression of YAP/TAZ may bestow
stem-like characteristics on normal mam-
mary cells as well.
To address this, we used fluorescence-
activated cell sorting (FACS) to isolate
terminally differentiated luminal cells (LD,
EpCAMhighCD49flowCD61) fromdissected
mousemammary glands (Guoet al., 2012; Figure 1A). LDcells ex-
pressed markers of terminal differentiation and, in culture, were
voidof anyproliferativepotential and remainedassinglecells (Fig-
ures S1B–S1D). This differs from the MaSC-enriched or luminal
progenitor (LP) fractions, which formed solid and cavitated col-
onies, respectively (Figure S1D). Endogenous YAP/TAZ proteins
and their transcriptional targets Ctgf and Axl were highly ex-
pressed in the MaSC-containing population but at much lower
levels in differentiated cells (Figures 1B and 1C).
To investigate whether ectopic expression of YAP or TAZ in LD
cells could impart MaSC-like properties, FACS-purified LD cells
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Figure 2. Lineage Tracing of yMaSCs
(A) Schematic of the genetic lineage tracing strategies to trace different mammary cell lineages.
(B and C) Immunostainings with anti-YFP of K8-CreER/R26-YFP-traced (B) or K14-CreER/R26-YFP-traced (C) cells during colony formation. Days indicate the
time in mammary colony medium. Scale bars, 62 mm.
See also Figure S2.were plated on collagen-coated dishes and transduced with
doxycycline (Doxy)-inducible lentiviral vectors encoding for
wild-type (WT) YAP or the activated versions of YAP and TAZ
(i.e., YAP5SA or TAZ4SA, lacking inhibitory phosphorylation
sites) (see the diagram in Figure 1D). As a control, cells were in-
fected with an inducible EGFP vector. Transduced cells were
cultured for 7 days in doxycycline-containing medium and then
plated at clonogenic density in three-dimensional 5% Matrigel
cultures (Experimental Procedures). Strikingly, cells expressing
either YAP or TAZ formed solid colonies indistinguishable from
those generated by MaSCs (Figures 1E and 1F) and very distinct
from the cysts generated by LP cells (Figure S1D). EGFP-ex-
pressing control cells invariably remained as single cells without
ever originating even a single colony in 33 experiments. As a
further control, the expression of transcriptionally deficient
YAPS94A (i.e., unable to interact with its DNA-binding partner
TEAD) also had no effect.
We then asked whether YAP/TAZ expression converted
luminal differentiated cells to a MaSC-like state. This includes
the ability to form colonies that can be serially passaged. Indeed,
YAP/TAZ-induced colonies, similarly to those generated from
MaSCs, could form additional generations of colonies after sin-
gle-cell dissociation (Figures 1G and 1H). Notably, colonies
could be passaged even after expression of ectopic YAP had
been turned off (by removing doxycycline) (Figures 1G, 1H and
S3A). This suggests that transient expression of YAP/TAZ is suf-
ficient to stably endow self-renewal potential to differentiated
mammary cells. We thus designated the YAP/TAZ-induced
‘‘MaSC-like’’ cells as ‘‘yMaSCs.’’
To verify whether the switch from LD to yMaSC could be reca-
pitulated at the single-cell level, individual LD cells were seeded
in 96-well plates (visually verified) and induced to express YAP.
By monitoring the resulting outgrowths, we found that these
individual cells formed solid colonies with high frequency (Fig-
ure S1F; 18.5% on average in the three independent experi-
ments). From this experiment, we also noticed that this fre-
quency of conversion, combined with the lack of colony-
forming cells in controls (0%), argues against the hypothesisthat yMaSCs arise from rare, contaminating, pre-existing stem/
progenitors in our LD preparations.
Of note, we also found that overexpressing YAP in the endog-
enous MaSC-enriched cell population does not increase its col-
ony-forming capacity (Figure S1G). In other words, even if rare
contaminant MaSCs were present, then these would remain
rare and not be expanded by YAP expression.
Validation of LD-to-yMaSC Conversion by Lineage
Tracing
To validate the notion that YAP expression converts differenti-
ated cells to an SC fate, we carried out reprogramming of LD
cells purified from K8-CreERT2; R26-LSL-YFP mice (Figure 2A),
allowing for a lineage tracing strategy to genetically label luminal
cells (Van Keymeulen et al., 2011). For this experiment, we first
FACS-purified LD cells (as in Figure 1A). After plating, cells were
exposed to a pulse of tamoxifen to activate the YFP tracer
exclusively in K8-positive cells and then infected with empty
or YAP-expressing vectors. Colonies generated by YAP reprog-
ramming of LD cells were entirely YFP-positive, confirming
their origin from the luminal lineage (Figures 2B and S2A). As
a control, we validated that the K8-CreERT2 tracing was
restricted to luminal cells. Tamoxifen-treated MaSCs from the
K8-CreERT2; R26-LSL-YFP mammary gland formed colonies
that were exclusively YFP-negative (n = 154, 0% YFP+) (Fig-
ure 2B). These results also argue against the possibility that
YFP-labeled yMaSCs could emerge from contaminating endog-
enous MaSCs.
The same conclusion was further validated by a complemen-
tary experiment in which we genetically labeled the basal/MaSC-
enriched cell population by using K14-CreERT2; R26-LSL-YFP
mice (Van Keymeulen et al., 2011; Figure 2A). LD cells and
MaSCs were sorted by FACS as above and then treated with a
pulse of tamoxifen to label K14-positive cells. YAP-reprog-
rammed LD cells purified from this genetic setup generated
yMaSC colonies that were invariably void of any YFP expression
(0%, n = 122) (Figure 2C). As a positive control, endogenous
MaSCs traced by K14-CreERT2 labeling formed YFP-positiveCell Stem Cell 19, 725–737, December 1, 2016 727
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Figure 3. Characterization of yMaSCs
(A) Representative images of yMaSC outgrowths at the indicated time points. Until day 14, cultures were in mammary colony medium. After transfer to organoid
conditions (see scheme in Figure 1D), 64%–75% of yMaSC colonies evolved as organoids and were maintained and passaged without doxycycline. Scale bar,
250 mm. See also Figure S3A for transgene expression.
(B–D) Organoids from MaSCs and yMaSCs (from YAP WT) expressed basal and/or stem (a-SMA, K14, p63) and luminal markers (K8, K19). Scale bars in IF
pictures, 17 mm). See also Figures S3D–S3F for yMaSCs from phosphomutant YAP/TAZ.
(E) Immunostainings with anti-YFP combined with either anti-K14 or anti-K8 antibodies of yMaSC-derived organoids obtained from K8-CreER/R26-YFP-traced
LD cells as in Figure 2A and Figure S2A. Scale bars, 49 mm.
(F) Organoids from MaSCs and yMaSCs (from YAPWT) expressed b-casein (qRT-PCR) when treated with prolactin. Data were normalized to Gapdh expression
and are presented as mean + SD. The results are representative of two independent experiments performed in triplicate. See also Figure S3G.
(G) Unsupervised hierarchical clustering of gene expression profiles in LD cells, organoids from MaSCs (M), and organoids from yMaSCs (yM). Each column
represents one separated biological sample. Genes are ordered according to the decreasing average expression level in LD cells. Representative genes up-
regulated in LD cells (red) or in MaSC- and yMaSC-derived organoids (green) are shown on the left.
(H–J) Mammary gland reconstitution generated by stably GFP-expressing yMaSCs (from YAP WT) in virgin females. (H) Whole-mount images (left, native GFP
fluorescence; right, hematoxylin staining). (I) Histological section. (J) Representative sections stained for GFP and the indicatedmarkers. See Figures S3I and S3J
for controls. Scale bars, 0.5 cm in (H) and 21 mm in (I) and (J).
(legend continued on next page)
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colonies (Figure 2C). Collectively, several lines of evidence indi-
cate that yMaSCs do not emerge from rare contaminating
MaSCs pre-existing in our LD preparation. We conclude from
these lineage-tracing experiments that YAP acts in differentiated
cells to reprogram them into a MaSC-like state.
The Expansion, Differentiation, and Regenerative
Potential of yMaSCs
We then examined whether yMaSCs are functionally equivalent
to mammary SCs, as determined by additional characteristic
properties of SCs, such as the ability to self-organize in vitro
into mammary tissue-like structures, to differentiate along
distinct lineages, and to regenerate a mammary tree in vivo after
injection into a cleared mammary fat pad. For this, we sought to
establish a long-term culture system that allows mammary SCs
to form mammary gland-like structures in vitro. MaSC- and
yMaSC-derived colonies were transferred and embedded into
100% Matrigel and overlaid with ‘‘organoid’’ medium (Sato
et al., 2009) in the absence of doxycycline. Under these condi-
tions, colonies underwent extensive budding and, by 2 weeks,
grew into large epithelial organoids (Figure 3A; Figures S3B
and S3C; see the legend of Figure 3A for quantification). Organo-
ids derived from yMaSCs were indistinguishable in growth
pattern, size, and frequency from those generated by natural
MaSCs. yMaSC-derived organoids were dissociated, replated
as single cells every 2 weeks, and cultured for at least 12 months
(i.e., >25 passages) without changes in growth pattern, plating
efficiency, and differentiation potential.
By histological examination, both MaSC and yMaSC organo-
ids were composed by a stratified epithelium reminiscent of
the histology of the mammary gland (E-cadherin-positive; Fig-
ure S3C). Internal cells surrounding a lumen-like cavity ex-
pressed differentiated luminal markers such as K8 and K19 (Fig-
ures 3B and 3C). Outer cells (either at external surfaces or
bordering inner folds) displayed expression of basal, myoepithe-
lial, and SC markers (K14, a-smooth muscle actin [a-SMA], p63)
(Figures 3B–3D). yMaSCs derived from K8-CreERT2; R26-
LSL-YFP-traced LD cells (as in Figure 2B) generated organoids
with YFP-positive and K14-positive basal cells (Figures 3E and
S2A), attesting to their origin from reprogrammed LD cells.
Furthermore, addition of a lactogenic stimulus triggered expres-
sion of a- and b-casein, indicative of alveolar (milk-producing)
cell differentiation (Figures 3F and S3G).
To molecularly characterize yMaSCs, we FACS-purified
yMaSCs from organoids and evaluated the expression of luminal
and basal and/or stem cell markers (Figure S3H). yMaSCs were
remarkably similar to native MaSCs (freshly purified from the
mammary gland) because they express basal markers (including
myoepithelial markers such as a-Sma and Myh11) but not
luminal markers (Claudin1, K8, K18, and K19). yMaSCs also ex-
press genes previously associated with various types of adult
mammary SCs, including DNp63, Lgr4/5/6, and Procr, and all
to levels comparable withMaSCs (Chakrabarti et al., 2014; Plaks
et al., 2013; Wang et al., 2015).(K and L) Mammary gland reconstitution generated by yMaSC organoids in
rescence; right, hematoxylin staining). (L) Histological section. Note that, upon
with milk. Scale bars, 0.5 cm in (K) and 21 mM in (L).
See also Figure S3.By unsupervised hierarchical clustering of gene expression
profiles, organoids from MaSCs or yMaSCs could not be distin-
guished (Figure 3G). Taken together, the results indicate that,
similar to authentic MaSCs, yMaSCs display self-renewal poten-
tial, generate self-organizing epithelial structures reminiscent of
the normal mammary gland, and retain multilineage differentia-
tion ability.
Next we tested whether yMaSCs displayed mammary gland
reconstituting activity. For this, FACS-purified LD cells were
transduced with vectors encoding for EGFP and inducible
wild-type YAP. Cells were treated with doxycycline for 7 days
and then transplanted (103–104 cells) into the cleared mammary
fat pads of non-obese diabetic (NOD)-severe combined immu-
nodeficiency (SCID) mice. Strikingly, cells that had experienced
transient expression of wild-type YAP had also acquired the abil-
ity to regenerate the mammary gland (25%, n = 16) (Figures 3H
and 3I). Ductal tree and terminal end buds were regenerated
when as few as 100 YAP-reprogrammed LD cells were im-
planted (33%, n = 6). As a control, LD cells transduced with
the sole EGFP vector did not display any reconstituting activity
at any inoculum dose (0%, n = 28, 102–53 104) (Figure S3I). His-
tological analyses revealed that the epithelial outgrowths ob-
tained from yMaSCs were EGFP-positive and morphologically
indistinguishable from those generated by endogenous MaSCs
and consisted of a bilayered epithelium composed of a basal
and/or myoepithelial layer (positive for K14 and a-SMA) overlaid
by luminal cells (positive for K8 and K19) (Figures 3J and S3J).
To explore the reconstituting potential of a single yMaSC, we
injected in the cleared fat pads single-cell derived organoids
and found that these were also able to regenerate the mammary
gland (33%, n = 6). Notably, when thesemice were impregnated,
reconstituted mammary glands generated a dense ductal sys-
tem ending in clusters of milk-secreting alveoli, indicating that
yMaSCs retain full differentiation potential in vivo (Figures 3K
and 3L). We conclude from this collective set of experiments
that transient expression of YAP/TAZ in differentiated cells of
the mammary gland is able to convert them into bona fide
MaSCs.
YAP/TAZ are not only instrumental for reprogramming of
differentiated mammary cells but also endogenously required
in MaSCs for preserving their self-renewal potential. Indeed,
we generated organoids from either endogenous MaSCs or
yMaSCs obtained from Yapfl/fl; Tazfl/fl mice; deletion of endoge-
nous YAP/TAZ by Adeno-Cre severely affected the ability of or-
ganoids to self-renew upon passaging (Figure S3K). Consis-
tently, we also found that conversion to the ySC state was
accompanied by activation of endogenous YAP/TAZ proteins.
As shown in Figure S3L, induction of exogenous YAP in LD cells
turned on expression of endogenous YAP and TAZ that re-
mained expressed in ySC-derived organoids after ectopic YAP
expression had been turned off (see Figure S3A for on-off control
of exogenous YAP expression). We conclude that transient
exposure to YAP/TAZ is sufficient to empower a self-sustaining
loop of endogenous YAP/TAZ expression.an impregnated female. (K) Whole-mount images (left, native GFP fluo-
gestation and lactation, the mammary gland is constituted by alveoli filled
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Figure 4. YAP Converts Neurons in yNSCs
(A) Schematic of the experiments performed with hippocampal or cortical neurons.
(B) Schematic of the genetic lineage tracing strategy used to trace neurons ex vivo.
(legend continued on next page)
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YAP Turns Neurons into Neural SC-like Cells
Neurons are post-mitotic cells that have been long considered
refractory to any cell fate change. Endogenous YAP and TAZ
proteins are highly expressed and transcriptionally active in neu-
ral stem cells (NSCs) but absent in neurons (Figures S4A–S4E),
prompting us to determine whether ectopic expression of YAP
in neuronswas sufficient to convert them into NSCs. Primary cul-
tures enriched in post-mitotic neurons (Figures 5A and S5A; see
below) were obtained from the hippocampus or cortex from late
mouse embryos (embryonic day 19 [E19]) or newborns. Cells
were cultured in serum-free neuronal differentiation medium
(Neurobasal with B27 containing vitamin A) also containing cyto-
sine b-D-arabinofuranoside (AraC) for 7 days to support neuronal
differentiation and eliminate proliferating cells (Figure 4A).
To follow the fate of post-mitotic neurons during YAP reprog-
ramming, we adopted redundant lineage tracing strategies to
stably label post-mitotic neurons. For this we prepared primary
neurons from the brain of Syn1-Cre or Thy1-Cre transgenic
mice expressing the Cre recombinase exclusively in post-mitotic
neurons under the control of a neuron-specific promoter (Zhu
et al., 2001; Dewachter et al., 2002) also bearing Cre-inducible
tracers from the R26 locus (Figure 4B). We validated that expres-
sion of the lineage tracer was restricted to cells displaying unam-
biguous neuronal morphology and markers, whereas none of
these traced cells was ever positive for NSCs and/or progenitor
markers, as detailed in Figures 4C, 4D, and 4H and Figures
S4F–S4H.
Primary cells were infected with lentiviral vectors encoding
for reverse tetracycline transactivator (rtTA) and inducible wild-
type YAP (Experimental Procedures). After AraC, neurons were
shifted to NSC medium in the presence of doxycycline (see
experimental outline in Figure 4A). Remarkably, after 2 weeks,
neurosphere-like structures emerged from YAP-expressing neu-
rons (P0 spheres) but never from neurons transduced with rtTA
alone or rtTA combined with empty vectors or transcriptionally
inactive YAPS94A (Figure 4E). Lineage-traced neurons from
Syn1-Cre; R26-CAG-LSL-tdTomato or Thy1-Cre; R26-LSL-(C) We confirmed, in primary neuronal cultures prepared from the brain of Syn1-
genic mice, that expression of the lineage tracer is indeed restricted to post-mito
and NEUN (95%, n = 252 cells). None of these traced cells were ever positive fo
liferation markers (5-Ethynyl-2’-deoxyridine [EdU], Ki67) (0%, n > 4,000 cells).
characterizations on Thy1-Cre-traced neuronal preparations.
(D) Immunofluorescence for the synaptic markers Synaptophysin and SV2A in c
bars, 11 mm (top) and 5.7 mm in magnifications (bottom).
(E) Table summarizing the results obtained in different lineage tracing experimen
(F) Lineage tracing experiment showing that yNSCs originate from neurons. The i
neurons from Syn1-Cre; R26-CAG-LSL-tdTomatomice and yNSCs derived from t
tdTomato NSCs are presented as a negative control.
(G) Panels are X-gal stainings of yNSCs derived from hippocampal neurons from
Neurospheres from Thy1-Cre; R26-LSL-LacZ NSCs (scale bar, 210 mm) are pres
(H) Lineage tracing experiment with the Syn1-Cre driver showing that yNSCs or
cortical neurons obtained from Syn1-Cre; R26-LSL-rtTA-IRES-EGFP mice. Rig
yNSCs obtained from the same neurons after transduction with doxycycline-ind
lineage tracing strategy using Thy1-Cre; R26-LSL-rtTA-IRES-EGFP mice.
(I–K) Representative images of yNSCs neurospheres (second passage, P2) deriv
transduced neurons are shown as a reference (I and J). Neurospheres from nativ
(L) P1 yNSCswere dissociated to single cells and replated at clonal density for neu
and P4). Native NSCs are presented for comparison. Graphs are quantifications
least eight (P2), six (P3), and three (P4) independent experiments performed in s
See also Figure S4.LacZ transgenic mice gave rise to tdTomato-positive or b-galac-
tosidase (b-gal)-positive neurospheres, respectively (Figures 4F
and 4G). Similarly, infection with tetO-YAP lentiviruses of neu-
rons from mice bearing Syn1-Cre or Thy1-Cre and the R26-
LSL-rtTA-IRES-EGFP reporter generated EGFP-positive yNSCs
(Figures 4H and S4G–S4I). In contrast, NSCs derived from the
same strains were invariably unlabeled (Figures 4F, left panel,
and 4G, left panel). This confirms that, as originally described
(Zhu et al., 2001; Dewachter et al., 2002), these drivers are not
active in natural NSCs; hence, YAP-induced NSCs, or ‘‘yNSCs,’’
originate from neurons rather than through amplification of pre-
existing, contaminating, endogenous NSCs.
By monitoring the process more closely using lineage-traced
neurons from Syn1-Cre; R26-CAG-LSL-tdTomato, we found
that Doxy addition triggered YAP expression in about 30% of
these neurons, and that, of these, 25% became positive for the
NSC marker Nestin 2–3 days after switching them to the NSC
medium (Figure S4J). This frequency of conversion, combined
with the fact that no Nestin-positive neurons were present before
YAP induction and no Nestin-positive neurons ever appeared in
control cultures, argues against the possibility that yNSCs arose
from rare pre-existing stem/progenitor cells in our neuronal
preparations. This is in line with the above conclusions drawn
from lineage tracing experiments.
Of note, we also found that overexpressing YAP in endoge-
nous NSCs does not increase neurosphere-forming capacity
(Figure S4K). Thus, even if rare contaminant NSCs were present,
then it seems these would remain rare and not be expanded by
YAP expression.
P0 spheres of yNSCswere transferred to new plates for further
growth and could then be propagated for several passages
as clonal outgrowths after single-cell dissociation, similarly to
native NSCs (Figures 4I–4L). Lineage tracing was retained
upon passaging (Figures 4F and 4G), indicating that YAP-reprog-
rammed neurons had acquired self-renewing properties.
The propagation of yNSCs as neurospheres did not require
addition of doxycycline, indicating that transient exposure toCre; R26-LSL-rtTA-IRES-EGFP or Syn1-Cre; R26-CAG-LSL-tdTomato trans-
tic neurons expressing TUJ1 (100%, n = 635 cells), TAU (100%, n = 140 cells),
r the NSCs and/or progenitor markers Nestin, Vimentin, or MASH1 or for pro-
See Figure S4F for representative images. See also Figure S4G for similar
ortical neurons derived from Syn1-Cre; R26-CAG-LSL-tdTomato mice. Scale
ts.
mages are bright-field and tdTomato-fluorescence pictures of primary cortical
hem (at the indicated passages). Neurospheres fromSyn1-Cre; R26-CAG-LSL-
Thy1-Cre; R26-LSL-LacZmice (scale bars, 210 mm) at the indicated passages.
ented as a negative control.
iginate from Syn1-traced neurons. Left: immunostaining for GFP and TUJ1 in
ht: bright-field and GFP fluorescence pictures of neurospheres derived from
ucible YAP. See also Figures S4G–S4I for similar results with the alternative
ed from hippocampal (I) or cortical (J) neurons. Images from negative control
e NSCs are presented for comparison (K). Scale bars, 210 mm.
rosphere formation in the absence of doxycycline for further passages (P2, P3,
of neurospheres formed by the indicated cells. Results are representative of at
ix replicates. Data are presented as mean + SD.
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Figure 5. Characterization of yNSCs
(A and B) Immunofluorescence for the indicated markers in hippocampal neurons (A) and P3 yNSCs plated as a monolayer (B). Endogenous NSCs served as a
positive control (scale bar, 23 mm). As shown in Figure S5B, Nestin-, SOX2-, and Vimentin-positive yNSCs derived from Thy1-Cre; R26-LSL-rtTA-IRES-EGFP
neuronal preparations are co-stained with EGFP, confirming their origin from differentiated cells.
(C) Unsupervised hierarchical clustering of gene expression profiles in cortical neurons, yNSCs, and NSCs. Each column represents one separated biological
sample. Genes are ordered according to the decreasing average expression level in neurons. Representative genes upregulated in neurons (red) or in NSCs and
yNSCs (green) are shown on the left.
(D–F) YAP-induced yNSCs and endogenous NSCs as a positive control were plated and differentiated toward an astrocytic, neuronal, or oligodendrocytic fate
(Experimental Procedures). Confocal images showing the astrocytic marker GFAP (D), the neuronal differentiation marker TUJ1 (E), and the oligodendrocytic
marker CNPase (F) are displayed. The results are representative of three independent experiments performed in triplicate. Scale bars, 50 mm. For neuronal
differentiation, see also Figures S5C–S5E, attesting acquisition of TAU and loss of Nestin expression.
(G–J) yNSCs were transduced with a constitutive EGFP-expressing vector and injected into the brains of recipient mice. Four weeks later, the brains were
fixed and processed for immunofluorescence analyses. (G and H) Representative confocal images showing that injected yNSCs (GFP-positive) integrate in the
brain parenchyma and massively differentiate into an astrocytic fate, as indicated by GFAP expression (arrows). V3, third ventricle; TH, thalamus. (I and J)
Representative confocal images showing injected yNSCs (GFP-positive) differentiated in NEUN- and TUJ1-positive neurons (I, arrows) or CNPase-positive
oligodendrocytes (J). Scale bars, 19 mm.
(K) Representative images of neurospheres from WT or Yapfl/fl; Tazfl/fl NSCs transduced with Ad-Cre. Scale bar, 250 mm.
(L) yNSCs (passage 4 as neurospheres) were dissociated, plated on fibronectin-coated dishes, and transfected with the indicated siRNAs. The graph represents
the quantification (mean ± SD) of neurospheres derived from the indicated cells.
See also Figure S5.exogenous YAP is sufficient to induce self-renewal properties
that are autonomously maintained. In line, as shown by experi-
ments with a Cre-excisable tetO-YAP lentiviral vector, post-re-
programming deletion of the whole YAP-encoding viral cassette
had no effects on yNSC maintenance (Figures S4L–S4N).732 Cell Stem Cell 19, 725–737, December 1, 2016Characterization of yNSCs
Next we characterized yNSCs by marker gene expression using
immunofluorescence, qRT-PCR, and gene profiling. As shown in
Figures 5A and 5B and Figures S5A and S5B, yNSCs completely
lost expression of the terminal differentiation markers present in
the original neurons (such as TUJ1, TAU, and NEUN) and,
instead, expressed high levels of NSC markers (Nestin, SOX2,
and Vimentin). Furthermore, we compared the transcriptome
of parental neurons, yNSCs, and native NSCs and found
that yNSCs completely lost their neuronal identity and acquired
a gene expression profile closely similar to native NSCs
(Figure 5C).
Neural SCs are defined as tripotent, as attested to by their abil-
ity to differentiate in astrocytes, neurons, and oligodendrocytes.
We therefore examined the differentiation potential of yNSCs by
placing them under appropriate culture conditions (Experimental
Procedures). yNSCs could differentiate into astrocytes, neurons,
and oligodendrocytes as defined by markers and morphology
(Figures 5D–5F and S5C–S5E) and thus are indeed tripotent.
To investigate the in vivo differentiation potential of yNSCs,
we transplanted EGFP-labeled yNSCs in the brain of newborn
mice (n = 5). Four weeks after transplantation, grafted yNSCs
invariably lost Nestin positivity (Figure S5F) and mainly remained
close to the injection site, where they primarily acquired expres-
sion of GFAP, indicative of astrocyte differentiation (Figures 5G
and 5H). Injected yNSCs also differentiated into NEUN- and
TUJ1-positive neurons or CNPase-positive oligodendrocytes
(Figures 5I and 5J). Importantly, no tumor formation was
ever observed after histological examination of the yNSCs-
injected brain parenchyma. Thus, YAP induces conversion of
neurons into cells that have functional properties similar to those
of normal NSCs.
As for MaSCs, endogenous YAP/TAZ are essential to sustain
the expansion of native NSCs in vitro because ex-vivo Adeno-
Cre-mediated deletion of YAP/TAZ from Yapfl/fl; Tazfl/fl NSCs
blunted neurosphere formation (Figure 5K). We further estab-
lished that the self-renewal properties of yNSCs are also sus-
tained by reactivation of endogenous YAP/TAZ. Two lines
of evidence support this conclusion. First, endogenous TAZ is
induced in yNSCs and remains as such after doxycycline with-
drawal and Cre-mediated excision of the tetO-YAP cassette
(Figure S5G). Second, YAP/TAZ depletion in yNSCs by trans-
fecting independent pairs of small interfering RNAs (siRNAs)
greatly impairs their self-renewal properties (Figure 5L). These
results raise an interesting parallel between the requirement of
YAP/TAZ in native NSCs and induced yNSCs.
Ex Vivo Generation of Pancreatic Progenitors from
Exocrine Cells
Pancreatic progenitors are rare in the normal pancreas but can
be regenerated by differentiated acinar exocrine cells upon injury
(Pan et al., 2013). Pancreatic progenitors are expandable in vitro
as ductal organoids (Huch et al., 2013; Figures 6A and 6B), and,
like MaSCs and NSCs, display nuclear and transcriptionally
active YAP/TAZ and genetically require YAP/TAZ for their prop-
agation (Figures S6A–S6C). Considering the intrinsic plasticity of
acinar cells, we used them as a third reprogramming paradigm,
askingwhether a transient pulse of YAP expression could be suf-
ficient to convert them into progenitors. To this end, we isolated
pancreatic acini from R26-rtTA; tetOYAPS127A adult mice and
dissociated them to obtain a single cell preparation. Cells were
plated in 100%Matrigel and cultured in the presence of doxycy-
cline in pancreas organoid medium. In just a few days, acinar
cells induced to express YAP, but not cells left without doxycy-cline, expanded as cyst-like organoids (Figures 6C and S6D).
Acinar cells derived from control R26-rtTAmice remained as sin-
gle cells or, more rarely, formed small cysts but never expand-
able organoids (Figure S6D). After initial derivation, YAP-induced
organoids (or ‘‘yDucts’’) could be passaged for several months
even in the absence of doxycycline and, thus, in the absence
of exogenous YAP/TAZ (for at least 10 passages, 6 months).
Individual organoids could be manually picked and expanded
as clonal lines. By morphology, size, and growth pattern, orga-
noids derived from converted acinar cells were comparable
with those obtained from handpicked pancreatic duct fragments
after whole pancreas dissociation (Huch et al., 2013; Figures 6B
and 6D).
As an alternative strategy, we embedded whole pancreatic
acini explanted from R26-rtTA; tetOYAPS127A in collagen and
cultured them under low-serum conditions known to preserve
acinar cell identity ex vivo (Means et al., 2005). When treated
with doxycycline to induce YAP expression (Figure S6E), pancre-
atic acini converted within a few days to ductal organoid struc-
tures andwith high efficiency (>70%) (Movies S1 and S2; Figures
S6F–S6H). As a control, acini lacking exogenous YAP expression
(e.g., left without doxycycline; Figure S6H) remained as such and
never converted to organoids. After transfer to 100% Matrigel-
pancreatic organoid medium, the YAP-induced ducts, but not
control acini, regrew into organoids and could be maintained
for several passages after single-cell dissociation even in the
absence of doxycycline (Figure S6G).
To validate that yDucts were indeed derived from differenti-
ated exocrine acinar cells, we carried out genetic lineage tracing
experiments using Ptf1a-CreERTM; R26-LSL-rtTA-IRES-EGFP;
tetO-YAPS127A mice (Figure S6I). In this genetic background,
tamoxifen treatment of adult mice causes irreversible genetic
tracing exclusively of pancreatic acinar cells (but not of endo-
crine, ductal, or centroacinar cells), as reported previously by
others (Pan et al., 2013) and revalidated here (Figure S6J). After
treatment, mice were kept without tamoxifen for 1 week, and
then pancreata were explanted to prepare whole acini or single
acinar cells that were cultured as above (see experimental
outline in Figure S6I). These EGFP-positive cells never formed
any organoid in the absence of doxycycline (Figures S6K and
S6L). Instead, doxycycline-induced YAP expression caused
the formation of expandable yDucts, that retained EGFP positiv-
ity over passaging, formally demonstrating their derivation from
terminally differentiated exocrine cells (Figures 6E, 6F, S6M,
and S6N; Movie S3). As a control of driver specificity in our cul-
ture conditions, organoids derived from endogenous ductal
progenitors explanted from Ptf1a-CreERTM; R26-LSL-rtTA-
IRES-EGFP; tetO-YAPS127A pancreata were never labeled by
EGFP (Figure S6O). This indicates that EGFP-traced yDucts
emerge from exocrine cells and not from pre-existing ductal
progenitors. In line with this conclusion, YAP overexpression
is inconsequential in endogenous ductal progenitors for their
clonogenic and organoid forming ability (Figure S6P), making
unlikely the possibility that YAP expression might expand rare
pre-existing contaminants.
We also performed a time course analysis of gene expression
dynamics occurring at the single-cell level during reprogram-
ming induced by tetO-Yap. As shown in Figure 6G, at the begin-
ning of the experiment, cells expressed exocrine markers (AmyCell Stem Cell 19, 725–737, December 1, 2016 733
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Figure 6. YAP Converts Pancreatic Acinar
Cells to Duct-like Organoids
(A and B) Representative images of a pancreatic
duct fragment growing in pancreatic organoid me-
dium at the indicated times (A) and after four pas-
sages in fresh Matrigel (B). Pictures are represen-
tative of three independent experiments performed
with four technical replicates. Scale bars, 290 mm.
(C and D) Serial images of a single acinar cell
derived from R26-rtTA; tetO-YAPS127A growing as
cyst-like organoids at the indicated time points after
Doxy addition (C) and after four passages in fresh
Matrigel in the absence of Doxy (D). Pictures are
representative of five independent experiments
performed with four technical replicates. Scale
bars, 70 mm in (C) and 290 mm in (D).
(E and F) Lineage tracing experiments using the
Ptf1a-CreERTM driver. Images are bright-field and
GFP fluorescence pictures of transgenic YAP-ex-
pressing exocrine cells at the indicated time points
of Doxy treatment (E) and after passaging in
absence of Doxy (F). See also Figure S6I for a
schematic of the experiment. Scale bars, 70 mm in
(E) and 130 mm in (F).
(G) Single-cell gene expression profile of pancreatic
cultures of the R26-rtTA; tetO-YAPS127A genotype
during the YAP-induced conversion of acinar cells
to yDucts. Rows are evaluated genes, and columns
are individual cells. Day 0, starting acini (without
doxycycline); day 2, cultures that experienced 48 hr
of doxycycline; day 4, cultures that experienced
96 hr of doxycycline. The heatmap represents
expression levels as log2 ratio normalized to 18S
rRNA.
(H) Organoids from duct fragments (Ducts, bottom,
as in B) and YAP-induced organoids (yDucts, cen-
ter) expressed the ductal marker SOX9 and were
negative for the exocrine marker Amylase (data not
shown) by immunofluorescence. Acinar cells (top)
are shown as a control. Scale bar, 80 mm.
(I) Unsupervised hierarchical clustering of gene
expression profiles in acini, yDucts, and Ducts.
Each column represents one separated biological
sample. Genes are ordered according to the
decreasing average expression level in acini.
Representative genes upregulated in acinar cells
(red) or in Ducts and yDucts (green) are shown on
the left.
See also Figure S6.and Ptf1a) but not markers of pancreatic progenitors or ductal/
centroacinar cells (Pdx1, Sox9, K19, and Car2), cell proliferation
(CyclinD1), or the YAP targets Ctgf and Myc (Zanconato et al.,
2015). After 2 days of doxycycline treatment, pancreatic progen-
itor markers were turned on in most cells and did so more734 Cell Stem Cell 19, 725–737, December 1, 2016robustly on day 4 and then in yDuct cells
(in line with what is shown in Movies S1,
S2, and S3). On days 2 and 4 (but not
in yDucts), most acinar cells retained
concomitant expression of acinar markers
and could thus be considered cells caught
in transition. We noticed that progenitor
markers were already present on day 2,before cells acquired expression of the proliferation marker
CyclinD1, indicating that phenotypic conversion into a ductal
progenitor state can be initially uncoupled from proliferation.
In section, yDuct-derived organoids appeared as epithelial
monolayers surrounding a central cavity (Figure 6H). By
qRT-PCR and immunofluorescence, organoids lost markers of
exocrine differentiation (Ptf1a, a-amylase, Elastase, and CPA1)
and acquired expression of ductal markers (K19, Sox9, Hes1,
and Cd44) and proliferative markers (cMyc and CyclinD1), all to
levels comparable with those of native ductal organoids (Figures
6H and S6Q). To determine the extent of YAP-induced conver-
sion of acinar cells and their molecular overlap with native ductal
progenitors, we carried out transcriptomic analyses. As shown in
Figure 6I, yDucts diverged from parental acinar cells to become
ostensibly similar to bona fide pancreatic progenitors. Under
differentiating conditions, yDuct-derived cells could be induced
to re-express the differentiated exocrine marker CPA1 and to
downregulate K19 (Figure S6R). When transplanted into the
pancreas of NOD-SCID mice, yDucts remained as such and
never formed any tumor (n = 6, data not shown), indicating that
yDucts are indeed non-transformed and non-tumorigenic.
Together, the results indicate that exocrine cells with a history
of exposure to YAP acquired key molecular and biological fea-
tures of ductal pancreatic progenitors.
DISCUSSION
Here we report that expression of a single factor into differenti-
ated cells explanted fromdistinct tissues induces cells with func-
tional and molecular attributes of their corresponding tissue-
specific SCs that can be expanded ex vivo. The ySC state can
be transmitted through cell generations without the need for
continuous expression of ectopic YAP/TAZ, indicating that a
transient activation of ectopic YAP or TAZ is sufficient to induce
a heritable self-renewing state. Differently from induced pluripo-
tent stem cells (iPSCs) or other reprogramming efforts, ySCs
preserve a memory of the tissue of origin, expanding the current
reprogramming paradigms by focusing on somatic stem cell
generation from related cells of the same lineage.
Several lines of evidence support the notion that ySCs origi-
nate from conversion of differentiated cells rather than from
amplification of rare pre-existing endogenous SCs. In particular,
we used lineage tracing strategies employing established Cre
drivers to label differentiated cells and follow their fate after
YAP-induction. We found that ySCs indeed retained the genetic
label specific of the original differentiated cells. Conversely, col-
onies and organoids emerging from native SCs were invariably
unlabeled by the same genetic tracers. In the case of the mam-
mary gland, we also used FACS to sort terminally differentiated
cells from luminal progenitors and show that YAP can effectively
operate on LD cells. Beyond lineage tracing, ySCs were induced
with relatively high frequency after YAP expression, whereas no
outgrowths emerged from differentiated cells expressing control
vectors or transcriptionally inactive YAP, a scenario that argues
against ySCs emergence from rare, pre-existing SCs. We also
entertained the possibility that YAP overexpression may selec-
tively expand rare native stem/progenitor cells. We consider
this possibility also unlikely because YAP expression has no ef-
fect on the colony-forming capacity and expandability of native
SCs. The latter finding is perhaps consistent with the fact that
native SCs cultured ex vivo already contain transcriptionally
active endogenous YAP/TAZ.
It is worth noting that, in mammary gland and pancreatic
acinar cells, we were able to obtain transition to the correspond-ing tissue SCs starting from mature, adult differentiated cells,
highlighting how YAP can imbue these lineages with a remark-
able plasticity. However, we carried out our reprogramming
experiments on fetal neurons because primary adult neurons
cannot be effectively cultured ex vivo. Although they are post-
mitotic, these early neurons may be particularly competent for
YAP-induced reprogramming. Future work and technological
advancements will be required to determine whether adult neu-
rons can be reprogrammed by YAP similarly to fetal neurons.
Our procedure generates cells with normal SC traits as sug-
gested by several lines of evidence: ySCs can be expanded
over multiple passages as self-expanding organoids or neuro-
spheres; ySCs readily generate a multilineage progeny reminis-
cent of the corresponding native SCs (for example, in the case
of yMaSCs, reprogrammedSCs generateminigland-like organo-
ids in vitro that, when transplanted in vivo, regenerate a normal
ductal tree in the cleared fat pad); ySCs are not transformed
and non-tumorigenic; and, at the transcriptional level, ySCs
display remarkable overlaps with their native counterparts.
Lineage plasticity and reversion to an SC-like status rarely
occur in normal tissues but are associated with tissue repair or
oncogenic activation (Blanpain and Fuchs, 2014). Of note, ge-
netic depletion of YAP and/or TAZ in several adult epithelia is
inconsequential for normal homeostasis but, in fact, essential
for regeneration, tumor growth (Zanconato et al., 2016), and,
as shown here, for expansion of somatic SCs in vitro. It is thus
tempting to propose that the path for lineage-specific reprog-
ramming outlined heremay be activated whenever natural, path-
ological, or ex vivo conditions demand generation and expan-
sion of new SCs using differentiated cells as facultative SCs
without losing tissue memory. Further work is required to vali-
date that YAP reprogramming can occur in vivo and particularly
in humans. If it does, it may be worth exploring means to exploit
this path to facilitate tissue repair and regeneration in distinct tis-
sues. From this perspective, the inability to cross lineage bound-
aries might represent a potential limitation for in vitro applica-
tions because some differentiated cells may not be readily
accessible. However, if the same strategy could be applied
directly in vivo, then the ability of a single factor to generate pro-
liferative and multipotent SCs while retaining tissue memory
would provide an advantage over other reprogramming and
transdifferentiation strategies that employ either complex
cocktails of transcription factors or the passing through an
embryonic-like pluripotent state (Bar-Nur et al., 2015; Xu et al.,
2015).
In conclusion, finding that YAP/TAZ, as a single factor, can
reprogram distinct cell types into their corresponding tissue-
specific SCs may have implications for regenerative medicine,
for discovering still unknown determinants of somatic stemness,
and, more broadly, for ad hoc expansion of somatic cells.
EXPERIMENTAL PROCEDURES
Primary Mammary Epithelial Cell Isolation and Induction of yMaSCs
Primary mammary epithelial cells (MECs) were isolated from the mammary
glands of 8- to 12-week-old virgin C57BL/6J mice (unless otherwise specified)
according to standard procedures (Stingl et al., 2006; see Supplemental
Experimental Procedures for details). Animal experiments were performed
adhering to our institutional guidelines, and approved by OPBA and the Minis-
try of Health. To separate various MEC subpopulations, cells were stained forCell Stem Cell 19, 725–737, December 1, 2016 735
30 min at 4C with antibodies against CD49f (phycoerythrin [PE]-Cy5, catalog
no. 551129, BD Biosciences), CD29 (PE-Cy7, catalog no. 102222, BioLegend),
CD61 (PE, catalog no. 553347, BD Biosciences), EpCAM (fluorescein isothio-
cyanate [FITC], catalog no. 118208, BioLegend), and lineagemarkers (allophy-
cocyanin [APC] mouse lineage antibody cocktail, catalog no. 51-9003632, BD
Biosciences) in DMEM/F12.
The stained cells were then resuspended in PBS/BSA 0.1% and sorted on a
BD FACS Aria sorter (BD Biosciences) into LD cells, LP cells, and MaSCs.
Primary sorted subpopulations from FACSwere plated on collagen I-coated
supports and cultured in two dimensions in mammary gland (MG) medium
(DMEM/F12 supplemented with glutamine, antibiotics, 10 ng/ml murine
epidermal growth factor [EGF], 10 ng/ml murine basic Fibroblast growth factor
(bFGF), and 4 mg/ml heparin with 2% fetal bovine serum [FBS]).
For induction of yMaSCs, LD cells were transduced for 48 hr with FUW-tetO-
YAP or FUW-tetO-TAZ in combination with rtTA-encoding lentiviruses. As a
(negative) control, LD cells were transduced with either FUW-tetO-EGFP (Fig-
ures 1E, 1F and S1F) in combination with rtTA-encoding lentiviruses. After
infection, adherent cells were washed and treated with 2 mg/ml doxycycline
for 7 days in MGmedium for activating tetracycline-inducible gene expression
(see scheme in Figure 1D) to obtain yMaSCs. After doxycycline treatment for
7 days in two-dimensional culture, yMaSCs were processed for further assays
or analysis. Unless otherwise specified, yMaSCs were generated from wild-
type YAP (FUW-tetO-WTYAP). For the experiment depicted in Figures 2B,
2C and S2A, we first FACS-purified LD cells and MaSC-enriched populations
(using CD61 and CD49f as described previously for Figure 1A) from K8-
CreERT2; R26-LSL-YFP/+ or K14-CreERT2; R26-LSL-YFP/+ virgin female
mice. These cells were plated, and, after attachment, they were treated with
1 mM 4-hydroxy (4OH)-tamoxifen for 24 hr. Cells were then transduced for
48 hr with FUW-tetO-WTYAP in combination with stable rtTA-encoding lenti-
viral supernatant. Negative control cells were provided by LD cells transduced
with FUW-tetO-MCS (empty vector) in combination with rtTA-encoding lentivi-
ral supernatants. After infection, cells were washed and treated with doxycy-
cline in MG medium as above.
Primary Neuron Isolation and Induction of yNSCs
Neurons were prepared from hippocampi or cortices of late (E18–19) embryos
or post-natal day 1 (P1) pups as described previously (Han et al., 2008). Briefly,
hippocampi and cortices were dissected under the microscope in ice-cold
Hank’s balanced salt solution (HBSS) as quickly as possible, incubated with
0.05% trypsin (Life Technologies) for 15 min at 37C, and, after trypsin block-
ing, resuspended in DMEM/10% FBS supplemented with 0.1 mg/ml DNase I
(Roche) and mechanically dissociated by extensive pipetting. Cells were
then plated on poly-L-lysine-coated wells in DMEM supplemented with 10%
FBS, glutamine, and antibiotics for hippocampal neurons or in DMEM/Neuro-
basal (1:1) supplemented with 5% FBS, 13 B27, glutamine, and antibiotics for
cortical neurons (day 1). After 24 hr (day 2), the medium of both hippocampal
and cortical preparations was changed to fresh DMEM/Neurobasal (1:1) sup-
plemented with 5% FBS, 13 B27, glutamine, and antibiotics. For reprogram-
ming experiments, neurons were infected on the following day (day 3) with
FUW-tetO-WTYAP and FUdeltaGW-rtTA viral supernatants. Negative controls
were provided by neurons transduced with FUdeltaGW-rtTA alone or in com-
bination with FUW-tetO-EGFP or FUW-tetO-MCS (empty vector). After 24 hr
(day 4), the medium was changed, and cells were incubated in Neurobasal
medium supplemented with 13 B27, glutamine, antibiotics, and 5 mM AraC
(Sigma) for an additional 7 days, at the end of which well differentiated, com-
plex network-forming neurons were visible. To induce yNSCs formation,
treated neurons were switched to NSC medium (DMEM/F12 supplemented
with 13 N2, 20 ng/ml murine EGF, 20 ng/ml murine bFGF, glutamine, and an-
tibiotics) and doxycycline for activating tetracycline-inducible gene expres-
sion. After 7 days, fresh doxycyclinewas added. Sphere formationwas evident
upon YAP induction after 14 days of doxycycline treatment. Spheres (P0
spheres) were mechanically detached from the plates by tapping and flushing
(not by trypsinizing), transferred into a 15-ml plastic tube, and left to sediment
(usually 5 min). After discarding the supernatant, spheres were dissociated
with 1-–2 ml of TrypLE Express (Life Technologies) and mechanical pipetting.
TrypLE Express was then diluted 1:5 in NSC medium, and cells were centri-
fuged and resuspended in NSC medium without doxycycline. For the succes-
sive passages, spheres were harvested and dissociated, and yNSCs were736 Cell Stem Cell 19, 725–737, December 1, 2016routinely cultured and passaged without doxycycline in NSC medium as for
normal NSCs.
Pancreatic Acinar Cell Isolation and Induction of yDucts
Primary pancreatic acini were isolated from the pancreata of 6- to 9-week-old
mice according to standard procedures (Means et al., 2005). Digested tissue
was filtered through a 100-mm nylon cell strainer. The quality of isolated acinar
tissue was checked under the microscope. For culture of entire acini, explants
were seeded in neutralized rat tail collagen type I (Cultrex)/acinar culture
medium (1:1) (Means et al., 2005), overlaid with acinar culture medium
(Waymouth’s medium [Life Technologies] supplemented with 0.1% FBS [Life
Technologies], 0.1%BSA, 0.2 mg/ml soybean trypsin inhibitor [SBTI], 13 insu-
lin-transferrin-selenium-ethanolamine [ITS-X] [Life Technologies], 50 mg/ml
bovine pituitary extract [BPE] [Life Technologies], 1mg/ml dexamethasone
[Sigma], and antibiotics) when collagen formed a gel. For culture of isolated
acinar cells, acini were further digested in 0.05% trypsin for 30 min at 37C
to obtain a single-cell suspension. Single acinar cells were plated in 100%
Matrigel. When Matrigel formed a gel, cells were supplemented with pancre-
atic organoid medium (advanced DMEM/F12 supplemented with 13 B27,
1.25 mM N-acetylcysteine, 10 nM gastrin, 50 ng/ml murine EGF, 100 ng/ml
human Noggin, 100 ng/ml human FGF10, 10 mM nicotinamide, 1 mg/ml
R-Spondin1, and antibiotics) supplemented with 0.2 mg/ml SBTI. For induc-
tion of pancreatic organoids, entire acini or single acinar cells of the indicated
genotypes cells were seeded in medium supplemented with 2 mg/ml doxycy-
cline. Negative control cells were cultured under the same conditions in
the absence of doxycycline. Cells were treated with 2 mg/ml doxycycline for
7 days, and organoid formation was morphologically followed.
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